サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629855

クリルオイルの世界市場（2024年～2031年）

Global Krill Oil Market - 2024-2031

出版日
ページ情報
英文 211 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
クリルオイルの世界市場（2024年～2031年）
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 211 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

クリルオイルの世界市場は、2023年に2億7,143万米ドルに達し、2031年には11億1,405万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは19.7%で成長する見込みです。

クリルオイル市場は近年、特に高濃度のオメガ3脂肪酸（EPAとDHA）、リン脂質、アスタキサンチンのような抗酸化物質など、その健康効果に対する消費者の意識の高まりによって大きな成長を遂げています。これらの成分は、心臓血管の健康増進、認知機能の強化、抗炎症作用など様々な健康上の利点に寄与しており、クリルオイルは健康志向の消費者の間で求められているサプリメントとなっています。

心臓病、肥満、認知機能の低下など、生活習慣に関連した健康問題の有病率の増加は、予防的な健康ソリューションへの需要を加速させ、市場の成長をさらに促進しています。クリルオイルに含まれるオメガ3脂肪酸、特にEPAとDHAは、トリグリセリドの低下、血圧の低下、内皮機能の改善、血栓症のリスクの低下など、心臓保護作用が広く研究されています。

これらの健康効果は、心血管系の健康全般を促進し、心臓発作や脳卒中のリスクを軽減する上で重要な役割を果たすため、クリルオイルは多くの消費者の健康習慣に欠かせないものとなっています。さらに、心臓、関節、認知の健康など、特定の健康上の懸念をターゲットにした新しい製剤を含む製品イノベーションにより、各社は参入範囲を拡大し、より幅広い健康志向の人々に対応できるようになり、市場の成長をさらに後押ししています。

ダイナミクス

慢性疾患の有病率の上昇

心臓病、糖尿病、がん、呼吸器疾患などの慢性疾患は、世界の健康問題であり、WHOによれば世界全体の死亡原因の74%を占めています。主な危険因子は、食生活の乱れ、運動不足、タバコの使用、大気汚染などです。オメガ3脂肪酸（EPAとDHA）と抗酸化物質のアスタキサンチンを豊富に含むクリルオイルは、有益なサプリメントとして注目されています。

オメガ3脂肪酸（EPAとDHA）と抗酸化物質アスタキサンチンを豊富に含むオメガ3脂肪酸は、炎症を抑え、心臓の健康を増進し、関節機能をサポートし、糖尿病などの代謝状態を管理し、慢性疾患と闘うための自然な方法を提供します。ヘルスケアへのアクセスが限られているために慢性疾患が蔓延している米国の恵まれない地域社会では、クリルオイルは費用対効果の高いソリューションとして役立ちます。クリルオイルの抗炎症作用は、心臓病リスクの低減、インスリン感受性の向上、酸化ストレスからの保護に役立ち、関節炎や呼吸器疾患などの症状を持つ人々に恩恵をもたらします。

各社の戦略

クリルオイル市場は、製品イノベーションと戦略的パートナーシップによって急成長しています。各社は、関節の健康や認知機能といった分野をターゲットに、オメガ3系、抗酸化物質、ビタミンを組み合わせた特殊な製剤を開発しています。例えば、NYO3は2024年に中国で、女性やスポーツユーザーの関節の健康に焦点を当てた多目的クリルオイル製品を発売し、Aker BioMarineのSuperba Boostクリルオイルはオーストラリアで、膝の痛みや変形性関節症に関する健康強調表示でARTGの承認を得た。

戦略的提携は、市場範囲をさらに拡大しています。アーカーバイオマリンは2024年、ブラジルでのクリルオイルの販売でKilyos Nutritionと提携し、持続可能な調達を確保し、Brenntag Specialtiesは東南アジアでの販売を拡大しました。このようなパートナーシップは、企業が新しい市場を開拓し、競争力を強化し、持続可能な健康補助食品に対する需要の高まりに応えるのに役立ちます。

クリルオイルの副作用

クリルオイルは、主に副作用が原因で、市場成長を妨げるいくつかの課題に直面しています。一般的な問題の一つは、胃のむかつき、下痢、膨満感、胸焼けなどの胃腸の不快感で、サプリメントを摂取することが難しくなります。場合によっては、高用量がこれらの症状を悪化させ、使用中止につながることもあります。さらに、クリルオイルは下部食道括約筋を弛緩させ、胸焼けや胸の灼熱感を引き起こす可能性があります。

アレルギー反応は、じんましんのような軽い症状から、呼吸困難のような重篤な問題まで様々です。特に高用量では、生臭い後味や魚のげっぷを経験するユーザーもいます。さらに、クリルオイルのオメガ3含有量には血液をサラサラにする作用があり、血液をサラサラにする薬を服用している人の出血リスクを高める可能性があります。また、クリルオイルの高用量が空腹時血糖値を上昇させる可能性を示唆する限定的な証拠もあり、糖尿病患者にとっては懸念事項かもしれません。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 慢性疾患の蔓延
      • 企業が採用した戦略
    • 抑制要因
      • クリルオイル摂取に伴う副作用
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • DMIの見解

第6章 形態別

  • カプセル
    • ソフトジェル
    • ハードジェル
  • 油
  • 粉
  • グミ

第7章 用途別

  • 人間
    • 心臓血管の健康
    • 循環改善
    • 心臓発作と脳卒中
    • その他
    • 一般的な栄養と健康
    • 女性の健康
    • 月経前症候群
    • 生理痛
    • 出生前の健康
    • その他
    • 関節と骨の健康
    • 変形性関節症
    • 骨粗鬆症
    • 関節の痛みと炎症
    • その他
    • 神経学の健康
    • 認知
    • メンタルヘルス
    • その他
    • 肌の健康
    • アンチエイジング
    • 水分補給と弾力性
    • その他
    • 目の健康
    • ドライアイ
    • 炎症
    • その他
    • その他
  • 動物
    • 栄養
    • 皮膚と毛皮の健康
    • 心臓の健康
    • 骨と関節の健康
    • その他

第8章 販売チャネル別

  • B2B
  • B2C

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第11章 企業プロファイル

  • AKER BIOMARINE.
    • 会社概要
    • ネイチャーポートフォリオと説明
    • 財務概要
    • 主な発展
  • Biocorp Co., Ltd.
  • Rimfrost AS
  • NYO3 INTERNATIONAL AS
  • Onnit Labs, Inc.
  • Transparent Labs
  • Nurtigold
  • Shandong Kangjing Marine Biotechnology Co., Ltd
  • Coastside Bio Resources
  • Reckitt Benckiser Group plc.
  • Artic Light Products AS
  • NWC Naturals Inc.

第12章 付録

目次
Product Code: FB2350

Overview

Global Krill Oil Market reached US$ 271.43 million in 2023 and is expected to reach US$ 1,114.05 million by 2031, growing with a CAGR of 19.7% during the forecast period 2024-2031.

The krill oil market has seen significant growth in recent years, driven by rising consumer awareness of its health benefits, particularly its high concentration of omega-3 fatty acids (EPA and DHA), phospholipids, and antioxidants like astaxanthin. These components contribute to various health advantages, including improved cardiovascular health, enhanced cognitive function, and anti-inflammatory effects, making krill oil a sought-after supplement among health-conscious consumers.

The increasing prevalence of lifestyle-related health issues, such as heart disease, obesity, and cognitive decline, has spurred demand for preventive health solutions, further propelling market growth. The omega-3 fatty acids in krill oil, particularly EPA and DHA, have been extensively studied for their cardioprotective effects, such as lowering triglycerides, reducing blood pressure, improving endothelial function, and decreasing the risk of thrombosis.

The health benefits play a significant role in promoting overall cardiovascular health and reducing the risk of heart attacks and strokes, making krill oil an essential part of many consumers' wellness routines. Additionally, product innovations, including new formulations targeting specific health concerns like heart, joint, or cognitive health, have allowed companies to expand their reach and cater to a wider range of health-conscious individuals, further driving the market's growth.

Dynamics

Rising Prevalence of Chronic Diseases

Chronic diseases like heart disease, diabetes, cancer, and respiratory disorders are major global health concerns, causing 74% of deaths worldwide according to WHO, with a disproportionate impact on low- and middle-income countries. Key risk factors include poor diets, physical inactivity, tobacco use, and air pollution. Krill oil, rich in omega-3 fatty acids (EPA and DHA) and the antioxidant astaxanthin, has emerged as a beneficial supplement.

It helps reduce inflammation, improve heart health, support joint function, and manage metabolic conditions like diabetes, offering a natural way to combat chronic diseases. In underserved US communities, where chronic diseases are more prevalent due to limited access to healthcare, krill oil can serve as a cost-effective solution. Its anti-inflammatory properties help reduce heart disease risk, improve insulin sensitivity, and protect against oxidative stress, benefiting individuals with conditions like arthritis and respiratory diseases.

Strategies Adopted by the Companies

The krill oil market is growing rapidly, driven by product innovation and strategic partnerships. Companies are developing specialized formulations combining omega-3s, antioxidants, and vitamins to target areas like joint health and cognitive function. For instance, NYO3 launched multipurpose krill oil products in China in 2024, focusing on joint health for women and sports users, while Aker BioMarine's Superba Boost Krill Oil gained ARTG approval in Australia for health claims related to knee pain and osteoarthritis.

Strategic collaborations are further expanding market reach. Aker BioMarine partnered with Kilyos Nutrition in 2024 to distribute krill oil in Brazil, ensuring sustainable sourcing, while Brenntag Specialties expanded distribution in Southeast Asia. These partnerships help companies tap into new markets, strengthen their competitive position, and meet the growing demand for sustainable health supplements.

Side Effects of Krill Oil

Krill oil faces several challenges that hinder its market growth, primarily due to side effects. One common issue is gastrointestinal discomfort, such as upset stomach, diarrhea, bloating, and heartburn, which can make the supplement difficult to tolerate. In some cases, high doses may worsen these symptoms, leading users to discontinue use. Additionally, krill oil can relax the lower esophageal sphincter, contributing to heartburn and a burning sensation in the chest.

Allergic reactions can range from mild symptoms like hives to severe issues like difficulty breathing. The fishy aftertaste or fish burps that some users experience, especially with higher doses. Furthermore, krill oil's omega-3 content may have a blood-thinning effect, increasing the risk of bleeding for individuals taking blood-thinning medications. There is also limited evidence suggesting that high doses of krill oil could raise fasting blood glucose levels, which may be a concern for people with diabetes.

Segment Analysis

The global krill oil market is segmented based on form, application, sales channel, and region.

Convenience, Efficacy, and Consumer Preference of Capsules

The global krill oil market is segmented based on form into capsules, oil, powder, and gummies. The capsule formulations dominate the market and are driven by the convenience, efficacy, and consumer preference for controlled dosages. Soft gel capsules dominate the market due to their superior bioavailability, ease of swallowing, and aesthetic appeal. It is popular among brands like WOW Life Science, Carbamide Forte, and Superba Krill.

The soft gels offer a palatable solution with minimal fishy aftertaste, making them a preferred choice for health-conscious consumers. Hard gel capsules are gaining traction among consumers who prioritize clean-label, allergen-free products. These capsules, valued for their simplicity and structural integrity, offer customization opportunities for targeted formulations like cognitive enhancement or joint support.

Geographical Penetration

High Demand for Products with Health Benefits in North America

The North American krill oil market has seen significant growth, driven by increasing awareness of its health benefits, especially its superior bioavailability compared to fish oil. The 2023 CRN Dietary Supplement Survey revealed that 77% of Americans use dietary supplements, with Omega-3 products among the most popular. Cardiovascular health is a key driver, as heart disease remains the leading cause of death in US, claiming over 659,000 lives annually (CDC, 2023).

Krill oil, rich in EPA and DHA, improves lipid profiles and reduces inflammation, lowering risks of heart attacks and strokes. A 2022 study in The American Journal of Clinical Nutrition confirmed that krill oil's phospholipid-bound Omega-3s are more bioavailable than triglyceride-bound Omega-3s in fish oil. Krill oil is also popular for general wellness, particularly in addressing women's health issues like PMS and prenatal care. A 2022 NCBI study showed Omega-3s help reduce PMS symptoms.

Joint health is another key market segment, with over 54 million US adults suffering from arthritis (2023 Arthritis Foundation Report). Krill oil's anti-inflammatory properties support those with arthritis and osteoporosis, improving mobility. The market continues to grow due to the trend toward preventive healthcare and consumer preference for sustainable, eco-friendly products. The 2023 GOED report highlights steady growth in Omega-3 consumption, and innovations are boosting consumer acceptance.

Competitive Landscape

The major global players in the market include AKER BIOMARINE, Biocorp Co., Ltd., Rimfrost AS, NYO3 INTERNATIONAL AS, Onnit Labs, Inc., Transparent Labs, Nurtigold, Shandong Kangjing Marine Biotechnology Co., Ltd, Coastside Bio Resources, Reckitt Benckiser Group plc., Artic Light Products AS, and NWC Naturals Inc.

Sustainability Analysis

Krill oil is gaining popularity as an eco-friendly alternative to traditional marine oils, with sustainability being a key selling point. Krill are abundant and reproduce quickly, making them a renewable resource for oil extraction. Leading suppliers, such as Aker BioMarine, follow Marine Stewardship Council (MSC)-certified sustainable fishing practices, ensuring healthy krill populations and protected marine ecosystems.

Sustainability is a key marketing strategy, especially for eco-conscious consumers, as seen with Schiff Vitamins, which sources its krill oil from certified sustainable fisheries. However, the risk of overharvesting grows with rising demand. Since krill are vital to marine ecosystems, sustainable management is crucial to maintain balance. Suppliers must uphold strict sustainability standards, ensure transparency, and innovate eco-friendly production methods as the market expands.

By Form

  • Capsules
    • Softgels
    • Hardgels
  • Oil
  • Powder
  • Gummies

By Application

  • Human Applications
    • Cardiovascular Health
  • Circulation Improvement
  • Heart Attacks and Strokes
  • Others
    • General Nutrition and Wellness
    • Women Health
  • Premenstrual Syndrome
  • Period Pains
  • Prenatal Health
  • Others
    • Joint and Bone Health
  • Osteoarthritis
  • Osteoporosis
  • Join Pains and Inflammation
  • Others
    • Neurology Health
  • Cognition
  • Mental Health
  • Others
    • Skin Health
  • Anti-Aging
  • Hydration and Elasticity
  • Others
    • Eye Health
  • Dry Eye
  • Inflammation
  • Others
    • Others
  • Animal Applications
    • Nutrition
    • Skin and Coat Health
    • Heart Health
    • Bone and Joint Health
    • Others

By Sales Channel

  • B2B
  • B2C

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In February 2024, Aker BioMarine partnered with Kilyos Nutrition to introduce Superba Krill oil in Brazil, focusing on heart, liver, pregnancy, and cognitive health. This collaboration aims to meet the demand for sustainable, science-backed alternatives to fish oil, expanding Aker BioMarine's presence in the Brazilian market.
  • In July 2024, NYO3 is expanding in China with a new series of multipurpose krill oil products for women and sports enthusiasts. The innovative supplement, infused with collagen and hyaluronic acid, aims to enhance eye and vision health, capitalizing on the growing consumer awareness of omega-3 benefits beyond traditional fish oil.
  • In July 2022, Aker BioMarine secured FDA approval for its krill products with astaxanthin as color additives in fish feeds, enhancing salmon flesh color. This approval benefits North American salmon farming, improving feed uptake, growth, health, and fillet quality with QRILL Aqua and QRILL High Protein.

Why Purchase the Report?

  • To visualize the global krill oil market segmentation based on form, application, sales channel and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous krill oil market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global krill oil market report would provide approximately 68 tables, 53 figures and 211 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Form
  • 3.2. Snippet by Application
  • 3.3. Snippet by Sales Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Chronic Diseases
      • 4.1.1.2. Strategies Adopted by the Companies
    • 4.1.2. Restraints
      • 4.1.2.1. Side Effects Associated with Krill Oil Consumption
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. By Form

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 6.1.2. Market Attractiveness Index, By Form
  • 6.2. Capsules
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Softgels
    • 6.2.4. Hardgels
  • 6.3. Oil
  • 6.4. Powder
  • 6.5. Gummies

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Human Applications
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Cardiovascular Health
    • 7.2.4. Circulation Improvement
    • 7.2.5. Heart Attacks and Strokes
    • 7.2.6. Others
    • 7.2.7. General Nutrition and Wellness
    • 7.2.8. Women Health
    • 7.2.9. Premenstrual Syndrome
    • 7.2.10. Period Pains
    • 7.2.11. Prenatal Health
    • 7.2.12. Others
    • 7.2.13. Joint and Bone Health
    • 7.2.14. Osteoarthritis
    • 7.2.15. Osteoporosis
    • 7.2.16. Join Pains and Inflammation
    • 7.2.17. Others
    • 7.2.18. Neurology Health
    • 7.2.19. Cognition
    • 7.2.20. Mental Health
    • 7.2.21. Others
    • 7.2.22. Skin Health
    • 7.2.23. Anti-Aging
    • 7.2.24. Hydration and Elasticity
    • 7.2.25. Others
    • 7.2.26. Eye Health
    • 7.2.27. Dry Eye
    • 7.2.28. Inflammation
    • 7.2.29. Others
    • 7.2.30. Others
  • 7.3. Animal Applications
    • 7.3.1. Nutrition
    • 7.3.2. Skin and Coat Health
    • 7.3.3. Heart Health
    • 7.3.4. Bone and Joint Health
    • 7.3.5. Others

8. By Sales Channel

  • 8.1. Introduction
  • 8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  • 8.3. Market Attractiveness Index, By Sales Channel
  • 8.4. B2B
    • 8.4.1. Introduction
    • 8.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.5. B2C

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. US
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. AKER BIOMARINE.
    • 11.1.1. Company Overview
    • 11.1.2. Nature Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Biocorp Co., Ltd.
  • 11.3. Rimfrost AS
  • 11.4. NYO3 INTERNATIONAL AS
  • 11.5. Onnit Labs, Inc.
  • 11.6. Transparent Labs
  • 11.7. Nurtigold
  • 11.8. Shandong Kangjing Marine Biotechnology Co., Ltd
  • 11.9. Coastside Bio Resources
  • 11.10. Reckitt Benckiser Group plc.
  • 11.11. Artic Light Products AS
  • 11.12. NWC Naturals Inc.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us